Clinical Trial Update: Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating molecular phenotyping to predict response in esophageal cancer patients receiving combination chemotherapy; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Cancer

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage IB Esophageal Adenocarcinoma, Stage IIA Esophageal Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2018-02-13